Open AccessThis article is
- freely available
Tissue Engineered Human Skin Equivalents
New Jersey Center for Biomaterials, Rutgers—The State University of New Jersey, Piscataway, NJ 08854, USA
Ernest Mario School of Pharmacy, Department of Pharmaceutics, Rutgers—The State University of New Jersey, Piscataway, NJ 08854, USA
* Author to whom correspondence should be addressed.
Received: 16 November 2011; in revised form: 15 December 2011 / Accepted: 26 December 2011 / Published: 6 January 2012
Abstract: Human skin not only serves as an important barrier against the penetration of exogenous substances into the body, but also provides a potential avenue for the transport of functional active drugs/reagents/ingredients into the skin (topical delivery) and/or the body (transdermal delivery). In the past three decades, research and development in human skin equivalents have advanced in parallel with those in tissue engineering and regenerative medicine. The human skin equivalents are used commercially as clinical skin substitutes and as models for permeation and toxicity screening. Several academic laboratories have developed their own human skin equivalent models and applied these models for studying skin permeation, corrosivity and irritation, compound toxicity, biochemistry, metabolism and cellular pharmacology. Various aspects of the state of the art of human skin equivalents are reviewed and discussed.
Keywords: human skin equivalents; tissue engineering; regenerative medicine; skin grafts; skin models
Citations to this Article
Cite This Article
MDPI and ACS Style
Zhang, Z.; Michniak-Kohn, B.B. Tissue Engineered Human Skin Equivalents. Pharmaceutics 2012, 4, 26-41.
Zhang Z, Michniak-Kohn BB. Tissue Engineered Human Skin Equivalents. Pharmaceutics. 2012; 4(1):26-41.
Zhang, Zheng; Michniak-Kohn, Bozena B. 2012. "Tissue Engineered Human Skin Equivalents." Pharmaceutics 4, no. 1: 26-41.